Search results for "Kidney Failure"

showing 10 items of 112 documents

A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dial…

2015

Chronic Kidney Disease (CKD) anemia is one of the main common comorbidities in patients undergoing End Stage Renal Disease (ESRD). Iron supplement and especially Erythropoiesis Stimulating Agents (ESA) have become the treatment of choice for that anemia. However, it is very complicated to find an adequate treatment for every patient in each particular situation since dosage guidelines are based on average behaviors, and thus, they do not take into account the particular response to those drugs by different patients, although that response may vary enormously from one patient to another and even for the same patient in different stages of the anemia. This work proposes an advance with respec…

Malemedicine.medical_specialtyAnemiamedicine.medical_treatmentPopulationHealth InformaticsIron supplementMachine learningcomputer.software_genreModels BiologicalEnd stage renal diseaseCohort StudiesMachine LearningRenal DialysismedicineHumansIntensive care medicineeducationDialysiseducation.field_of_studybusiness.industryAnemiamedicine.diseaseAnemia managementComputer Science ApplicationsLarge cohortKidney Failure ChronicFemaleArtificial intelligencebusinesscomputerKidney diseaseComputers in Biology and Medicine
researchProduct

Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure.

2001

Incidence, risk factors, and prognosis of gastrointestinal hemorrhage complicating acute renal failure. Background Few prospective data are currently available on acute gastrointestinal hemorrhage (AGIH) as a complication of acute renal failure (ARF). The aim of the present study was to define incidence, sources, risk factors, and outcome of AGIH in patients with ARF. Methods We performed a prospective study on an inception cohort of 514 patients admitted for ARF to a nephrology intermediate care unit. Data on clinical risk factors for bleeding, frequency of occurrence of AGIH, length of hospital stay, and in-hospital mortality were collected. Independent predictors of AGIH were identified.…

Malemedicine.medical_specialtyCohort StudiesRisk FactorsInternal medicineIntensive careSeverity of illnesshistamine2-receptor antagonistsmedicineHumansHospital MortalityProspective StudiesRisk factorProspective cohort studybleeding complicationintensive careAgedbusiness.industryIncidenceAcute kidney injuryOdds ratioAcute Kidney InjuryLength of StayMiddle Agedmedicine.diseasePrognosiskidney failureSurgerycritical careItalyNephrologyhemostasisFemaleUpper gastrointestinal bleedingbusinessGastrointestinal HemorrhageKidney diseaseKidney international
researchProduct

Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report

2012

Transplantation in patients with congenital bleeding disorders is a challenge requiring an integrated approach of various specialists. Renal transplantation, the most frequent type of solid organ transplantation, is rarely performed in individuals with congenital hemorrhagic disorders. We performed a renal transplantation in a 53-year-old man with end-stage renal disease and congenital coagulation factor VII deficiency, a rare bleeding disorder with a peculiar clinical picture requiring replacement therapy in surgical interventions. Perioperative bleeding was successfully prevented by administration of recombinant activated factor VII. Treatment schedule, administration rate, and long-term …

Malemedicine.medical_specialtyDiseaseHemorrhagic disorderchemistry.chemical_compoundHumansMedicinekidney transplatation congenital bleeding disorders factor VII deficiency recombinant factor VII major surgerykidney transplantation inherited coagulation disorderCoagulation factor VIIKidney transplantationTransplantationFactor VIIbusiness.industryPerioperativeMiddle Agedmedicine.diseaseKidney TransplantationSurgeryTransplantationchemistryTreatment ScheduleFeasibility StudiesKidney Failure ChronicSurgerybusiness
researchProduct

Chronic renal failure: leukocyte rheology and polymorphonuclear cytosolic Ca2+ concentration.

2000

In a group of subjects with chronic renal failure (CRF), we evaluated the leukocyte rheological activity, expressed as the filtration rate, the polymorphonuclear (PMN) membrane fluidity and the PMN cytosolic Ca2+ content. Using the St. George's Filtrometer, we determined the filtration rate of unfractionated, mononuclear and PMN leukocytes. Using the fluorescent probe 1.4-(trimethylamino)-phenyl-4-phenyl-hexatriene (TMA-DPH), we examined the PMN membrane fluidity and, using the Fura 2-AM, the PMN cytosolic Ca2+ content. From the results obtained, it is evident that only the initial relative flow rate of unfractionated leukocytes was significantly reduced in subjects with CRF, while the filt…

Malemedicine.medical_specialtyMembrane FluidityNeutrophilschemistry.chemical_elementLeukocyte filtrationCalciumCytosolInternal medicineCa2 concentrationmedicineMembrane fluidityLeukocytesHumansbusiness.industryhemic and immune systemsGeneral MedicineMiddle Agedmedicine.diseasePathophysiologyCytosolEndocrinologychemistryCase-Control StudiesHemorheologyLinear ModelsChronic renal failureKidney Failure ChronicCalciumFemalebusinessKidney diseaseCurrent medical research and opinion
researchProduct

Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy--a Spanish multicentre experience.

2006

Background. Timely referral, preparation and initiation of dialysis remain problematic issues. The purpose of this study is to analyse the effect of chronic renal disease care and education on the mode of dialysis start (planned vs non-planned) and on the modality of renal replacement therapy (RRT). Methods. A total of 1504 patients from 35 hospitals started RRT in 2003. Out-patient, scheduled initiation of dialysis with a permanent vascular or peritoneal access was considered planned. Results. About 46% of the patients started non-planned dialysis. Of all the patients, 75% had 3 months of nephrological follow-up, but nearly half were never educated on dialysis options. Haemodialysis (HD) o…

Malemedicine.medical_specialtyPediatricsReferralmedicine.medical_treatmentPeritoneal dialysisEnd stage renal diseasePatient Education as TopicRenal DialysismedicineDiabetes MellitusHumansRenal replacement therapyVascular DiseasesIntensive care medicineDialysisRetrospective StudiesTransplantationbusiness.industryRetrospective cohort studyMiddle Agedmedicine.diseaseNephrologyKidney Failure ChronicFemaleKidney Cortex NecrosisHemodialysisbusinessPeritoneal DialysisKidney diseaseNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
researchProduct

Elastase, myeloperoxidase, nitric oxide metabolites and oxidative status in subjects with clinical stable chronic renal failure on conservative treat…

2009

We evaluated, in a group of 41 CRF undialyzed subjects (29 men and 12 women, mean age 64.1 +/- 11.3 years), some parameters that reflect leukocyte activation (elastase, myeloperoxidase - MPO), plasma NO metabolites (NO(x)) and the oxidative status (lipid peroxidation expressed as thiobarbituric acid-reactive substances (TBARS) and total antioxidant status (TAS). Elastase was determined, on plasma separated from fasting venous blood, as elastase/alpha1-proteinase inhibitor complex. MPO was evaluated employing the Myeloperoxidase ELISA kit. The NO production was evaluated by a micromethod. The oxidation of polyunsaturated fatty acids was evaluated in plasma by detection of the thiobarbituric …

Malemedicine.medical_specialtyPhysiologyRenal functionThiobarbituric Acid Reactive SubstancesLipid peroxidationchemistry.chemical_compoundchronic renal failurenitric oxidePhysiology (medical)Internal medicineTBARSLeukocytesMedicineHumanselastaseAgedPeroxidasechemistry.chemical_classificationCreatininebiologyPancreatic Elastasebusiness.industryElastaseHematologyMiddle Agedoxidative statuOxidative StressmyeloperoxidaseEndocrinologychemistrySpectrophotometryMyeloperoxidaseCase-Control StudiesImmunologybiology.proteinKidney Failure ChronicFemaleHemoglobinCardiology and Cardiovascular MedicinebusinessPolyunsaturated fatty acid
researchProduct

Assessment of cerebral microbleeds by susceptibility-weighted imaging at 3T in patients with end-stage organ failure

2018

Purpose: Cerebral microbleeds (CMBs) are small rounded lesions representing cerebral hemosiderin deposits surrounded by macrophages that results from previous microhemorrhages. The aim of this study was to review the distribution of cerebral microbleeds in patients with end-stage organ failure and their association with specific end-stage organ failure risk factors. Materials and methods: Between August 2015 and June 2017, we evaluated 15 patients, 9 males, and 6 females, (mean age 65.5 years). Patients population was subdivided into three groups according to the organ failure: (a) chronic kidney failure (n = 8), (b) restrictive cardiomyopathy undergoing heart transplantation (n = 1), and (…

Malemedicine.medical_specialtyRadiology Nuclear Medicine and Imagingmedicine.medical_treatmentPopulationLiver transplantationOrgan transplantation030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineMagnetic resonance imagingRisk FactorsmedicineHumanseducationNeuroradiologyAgedCerebral HemorrhageHeart transplantationeducation.field_of_studyCardiomyopathy RestrictiveTransplantationbusiness.industryCerebral microbleedGeneral MedicineSusceptibility-weighted imagingEnd-stage organ failureLiver TransplantationTransplantationCerebral microbleeds; End-stage organ failure; Magnetic resonance imaging; Susceptibility-weighted imaging; Transplantation; Radiology Nuclear Medicine and ImagingHemosiderinSusceptibility weighted imagingHeart TransplantationKidney Failure ChronicFemaleRadiologybusiness030217 neurology & neurosurgeryLiver Failure
researchProduct

Accumulation of hydroxyethyl starch (HES) in the liver of patients with renal failure and portal hypertension

1986

Summary Hydroxyethyl starch (HES) has gained wide clinical acceptance as a colloidal plasma substitute. We were able to study the liver biopsies of two patients with renal failure who developed ascites after repeated infusions of HES. All types of liver cells displayed massive accumulation of HES with the morphologic resemblance to a storage disease. These changes could be distinguished clearly from the lesions of a hereditary disorder by light and electron microscopy. Although it is difficult to establish a causative role for HES in the development of ascites on the bases of morphological changes alone, one should be cautious about giving HES to patients with renal failure until exact data…

Malemedicine.medical_specialtyResuscitationPathologyHydroxyethyl starchHydroxyethyl Starch DerivativesRenal DialysisHypertension PortalAscitesmedicineHumansreproductive and urinary physiologyHepatologybusiness.industryStarchMiddle Agedmedicine.diseaseSurgeryMicroscopy ElectronLiverKidney Failure ChronicPortal hypertensionFemaleHypotensionbiological phenomena cell phenomena and immunitymedicine.symptombusinessPerfusionmedicine.drugJournal of Hepatology
researchProduct

Xerostomia, thirst, sodium gradient and inter-dialytic weight gain in hemodialysis diabetic vs. non-diabetic patients

2017

Background In hemodialysis (HD) patients, xerostomia and hyposalivation may intensify sensations of thirst, and contribute to the intake of fluids and excessive inter-dialytic weight gain (IWG). Since IWG is regarded to be higher in diabetic patients than in non-diabetics HD enhancing their mortality, it is crucial to define plausible underlying causes. Therefore, the study investigates factors contributing to the increased IWG in diabetic HD patients. Material and Methods The study included 97 HD patients (38 diabetics) receiving hemodialysis. All participants completed surveys comprising the Dialysis Thirst Inventory (DTI) and Xerostomia Inventory. Unstimulated whole saliva flow rate (USW…

Malemedicine.medical_specialtySalivaSodiummedicine.medical_treatment030232 urology & nephrologychemistry.chemical_elementWeight GainGastroenterologyXerostomiaThirst03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicineDiabetes mellitusMedicineHumansDiabetic NephropathiesGeneral DentistryDialysisbusiness.industryResearchSodium030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMedically compromised patients in DentistryOtorhinolaryngologychemistryConcomitantUNESCO::CIENCIAS MÉDICASKidney Failure ChronicSurgeryFemaleHemodialysismedicine.symptombusinessWeight gainThirst
researchProduct

Inappropriately high left ventricular mass: Marker of very high cardiovascular risk in patients with chronic kidney disease

2012

There is increasing knowledge of the burden of cardiovascular (CV) diseases affecting patients with chronic kidney disease (CKD). CV diseases are the main cause of death in the CKD population, and the majority of patients with CKD die before ever reaching the end-stage renal disease; in fact, for patients with CKD, the risk of a fatal CV event is much higher than the risk to develop end-stage renal disease. Although patients with CKD manifest a high prevalence of traditional CV risk factors, this does not fully account for the burden of CV diseases in CKD.

Malemedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryPhysiologymedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareLeft ventricular massEndocrinologyCardiovascular DiseasesInternal medicineCardiovascular DiseasemedicineCardiologyInternal MedicineHumansKidney Failure ChronicIn patientFemaleHypertrophy Left VentricularbusinessCardiology and Cardiovascular MedicineUltrasonographyKidney diseaseHuman
researchProduct